BMJ-瑞卢戈利克斯联合恩扎鲁胺用于新辅助 辅助治疗高危局部晚期前列腺癌 Neoadjuvant adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer study protocol of the RENAPCA phase Ib trial.pdfVIP

  • 2
  • 0
  • 约19.63万字
  • 约 8页
  • 2026-06-16 发布于广东
  • 举报

BMJ-瑞卢戈利克斯联合恩扎鲁胺用于新辅助 辅助治疗高危局部晚期前列腺癌 Neoadjuvant adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer study protocol of the RENAPCA phase Ib trial.pdf

OpenaccessProtocol

Neoadjuvant/adjuvantrelugolixand

B

enzalutamideforthetreatmentofhigh-M

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档